Skip to main content

House Committee Moving Forward with Subpoena Regarding Medicare Advantage Demonstration Project

Written by Theresa C. Carnegie

As discussed in our recent post on the new Medicare Advantage (MA) star ratings, there is ongoing controversy regarding HHS’s Medicare Advantage Quality Bonus Payment Demonstration Project.  The Demonstration Project is intended to test an alternative method for computing quality bonus payments and, unlike the quality bonus payment structure under the Affordable Care Act, it allows for the payment of quality bonuses to MA plans with less than four stars.  Although HHS believes that the project provides a strong incentive for MA plans to improve performance at various star rating levels, critics have questioned the design, efficacy, and true intentions of the project.  This summer, the House Committee on Oversight and Government Reform held a hearing on the project where experts from the Government Accountability Office (GAO) raised concerns regarding the project and recommended its cancellation.

Now, Congressional Republicans are threatening to issue a subpoena if HHS does not produce requested documents regarding the Demonstration Project. In an October 17th  letter, House Oversight Committee Chairman Darrell Issa (R-CA) stated that if the Committee did not receive all requested documents by 5:00 p.m. on October 18, 2012, it would “move ahead with the use of compulsory process.” 

MA plans will want to closely monitor the outcome of this back and forth between HHS and the Committee.  Without the Demonstration Project, MA Plans will be subject to the Affordable Care Act’s quality bonus provisions and only those plans with a star rating of 4 stars or higher will be eligible for quality bonus payments.  

Subscribe To Viewpoints

Authors

Karen S. Lovitch

Member / Chair, Health Law Practice

Karen S. Lovitch is a Mintz attorney who represents health care companies in regulatory, transactional, and operational matters. She advises them on health care regulations such as the Stark Law and the Clinical Laboratory Improvement Amendments of 1988.
Theresa C. Carnegie is a Mintz attorney who advises health care clients on a wide array of transactional, regulatory, compliance, fraud and abuse matters, and health law issues. She counsels health plans, pharmacy benefit managers, pharmacies, device manufacturers, and distributors.